Let’s look at the key reasons that are pushing Adverum Biotechnologies Inc (ADVM) to new highs

Adverum Biotechnologies Inc (NASDAQ: ADVM) on Monday, soared 15.03% from the previous trading day, before settling in for the closing price of $1.73. Within the past 52 weeks, ADVM’s price has moved between $0.61 and $2.97.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Healthcare Sector giant saw their annual sales slid by -71.12% over the last five years. The company achieved an average annual earnings per share of 20.16%. With a float of $77.13 million, this company’s outstanding shares have now reached $100.12 million.

Adverum Biotechnologies Inc (ADVM) Breakdown of a Key Holders of the stock

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Adverum Biotechnologies Inc is 23.66%, while institutional ownership is 53.76%. The most recent insider transaction that took place on Feb 07, was worth 175,500. In this transaction Director of this company bought 130,000 shares at a rate of $1.35, taking the stock ownership to the 130,000 shares. Before that another transaction happened on Feb 07, when Company’s Director bought 100,000 for $1.35, making the entire transaction worth $135,000. This insider now owns 100,000 shares in total.

Adverum Biotechnologies Inc (ADVM) Recent Fiscal highlights

As on 9/29/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.33 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.31) by -$0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 20.16% per share during the next fiscal year.

Adverum Biotechnologies Inc (NASDAQ: ADVM) Trading Performance Indicators

Adverum Biotechnologies Inc (ADVM) is currently performing well based on its current performance indicators. A quick ratio of 4.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 55.85.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.26, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -0.91 in one year’s time.

Technical Analysis of Adverum Biotechnologies Inc (ADVM)

Analysing the last 5-days average volume posted by the [Adverum Biotechnologies Inc, ADVM], we can find that recorded value of 7.01 million was better than the volume posted last year of 2.71 million. As of the previous 9 days, the stock’s Stochastic %D was 45.57%. Additionally, its Average True Range was 0.30.

During the past 100 days, Adverum Biotechnologies Inc’s (ADVM) raw stochastic average was set at 56.05%, which indicates a significant increase from 53.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 250.32% in the past 14 days, which was higher than the 127.84% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.0324, while its 200-day Moving Average is $1.2813. Now, the first resistance to watch is $2.1533. This is followed by the second major resistance level at $2.3167. The third major resistance level sits at $2.5633. If the price goes on to break the first support level at $1.7433, it is likely to go to the next support level at $1.4967. Now, if the price goes above the second support level, the third support stands at $1.3333.

Adverum Biotechnologies Inc (NASDAQ: ADVM) Key Stats

Market capitalization of the company is 201.05 million based on 101,027K outstanding shares. Right now, sales total 0 K and income totals -154,540 K. The company made 0 K in profit during its latest quarter, and -31,510 K in sales during its previous quarter.